Sharon L Manne1, Shannon Myers-Virtue2, Deborah A Kashy3, Melissa Ozga4, David Kissane5, Carolyn Heckman6, Mark Morgan7. 1. Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. 2. Temple University School of Dentistry, Philadelphia, USA. 3. Michigan State University, Michigan, USA. 4. Memorial Sloan Kettering Cancer Center, New York, USA. 5. Monash University, Melbourne, Australia. 6. Fox Chase Cancer Center, Philadelphia, USA. 7. University of Pennsylvania School of Medicine, Philadelphia, USA.
Abstract
OBJECTIVE: Although a number of effective psychotherapies have been identified for cancer patients, little is known about therapy processes, as they unfold the course of treatment and the role of therapy processes in treatment outcome. We used growth curve modeling to evaluate the associations between therapy processes and outcomes among gynecological cancer patients participating in 2 types of therapy. METHODS:Two hundred twenty five women newly diagnosed with gynecological cancer were randomly assigned to receive 8 sessions of a coping and communication intervention or a client-centered supportive therapy. Participants completed measures of preintervention and postintervention depression, working alliance after Session 2, and postsession progress and depressive symptoms after each session. Therapists completed measures of perceived patient progress. RESULTS: Both patients and therapists reported a steady increase in session progress and patients reported a steady decrease in depressive symptoms over the course of both the coping and communication intervention and client-centered supportive sessions. Perceived progress in one session predicted progress in the subsequent session. Early working alliance predicted improved session progress and reductions in postsession depressive symptoms over sessions. Working alliance did not predict prepost treatment changes in depression. Patient-rated session progress predicted greater reductions in pretreatment to posttreatment depression, but therapist-rated progress did not. CONCLUSIONS: For 2 types of treatment delivered to women diagnosed with gynecological cancer, patient-rated session progress and depressive symptoms rated over therapy sessions may serve as a yardstick that can be useful to therapists to gauge patient's response to treatment.
RCT Entities:
OBJECTIVE: Although a number of effective psychotherapies have been identified for cancerpatients, little is known about therapy processes, as they unfold the course of treatment and the role of therapy processes in treatment outcome. We used growth curve modeling to evaluate the associations between therapy processes and outcomes among gynecological cancerpatients participating in 2 types of therapy. METHODS: Two hundred twenty five women newly diagnosed with gynecological cancer were randomly assigned to receive 8 sessions of a coping and communication intervention or a client-centered supportive therapy. Participants completed measures of preintervention and postintervention depression, working alliance after Session 2, and postsession progress and depressive symptoms after each session. Therapists completed measures of perceived patient progress. RESULTS: Both patients and therapists reported a steady increase in session progress and patients reported a steady decrease in depressive symptoms over the course of both the coping and communication intervention and client-centered supportive sessions. Perceived progress in one session predicted progress in the subsequent session. Early working alliance predicted improved session progress and reductions in postsession depressive symptoms over sessions. Working alliance did not predict prepost treatment changes in depression. Patient-rated session progress predicted greater reductions in pretreatment to posttreatment depression, but therapist-rated progress did not. CONCLUSIONS: For 2 types of treatment delivered to women diagnosed with gynecological cancer, patient-rated session progress and depressive symptoms rated over therapy sessions may serve as a yardstick that can be useful to therapists to gauge patient's response to treatment.
Authors: Sharon L Manne; Stephen Rubin; Mitchell Edelson; Norman Rosenblum; Cynthia Bergman; Enrique Hernandez; John Carlson; Thomas Rocereto; Gary Winkel Journal: J Consult Clin Psychol Date: 2007-08
Authors: Tina R Norton; Sharon L Manne; Stephen Rubin; John Carlson; Enrique Hernandez; Mitchell I Edelson; Norman Rosenblum; David Warshal; Cynthia Bergman Journal: J Clin Oncol Date: 2004-03-01 Impact factor: 44.544
Authors: Shannon B Myers; Sharon L Manne; David W Kissane; Melissa Ozga; Deborah A Kashy; Stephen Rubin; Carolyn Heckman; Norman Rosenblum; Mark Morgan; John J Graff Journal: Gynecol Oncol Date: 2012-10-23 Impact factor: 5.482